IL25 and cancer: IL-25 signaling is proposed to be involved in infection, asthma and allergy, psoriasis, autoimmunity including inflammatory bowel disease (IBD), rheumatoid arthritis, multiple sclerosis, Sjögren’s Syndrome and cancer (56–59).